These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8906230)

  • 1. Defining the regions of human interleukin-5 important in receptor binding and cellular activation.
    Wells TN; Graber P; McKinnon M; Banks M; Fattah D; Solari R; Peitsch MC; Proudfoot AE
    Ann N Y Acad Sci; 1996 Oct; 796():226-34. PubMed ID: 8906230
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation.
    Graber P; Proudfoot AE; Talabot F; Bernard A; McKinnon M; Banks M; Fattah D; Solari R; Peitsch MC; Wells TN
    J Biol Chem; 1995 Jun; 270(26):15762-9. PubMed ID: 7797578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of three human interleukin 5 structures suggests a possible receptor binding mechanism.
    Verschelde JL; Ampe C; Guisez Y; Oefner C; Vandekerckhove J; Tavernier J
    FEBS Lett; 1998 Mar; 424(3):121-6. PubMed ID: 9539134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.
    Tavernier J; Tuypens T; Verhee A; Plaetinck G; Devos R; Van der Heyden J; Guisez Y; Oefner C
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5194-8. PubMed ID: 7761472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 5 interactions with soluble and cell surface forms of its receptor.
    Li J; Cook R; Chaiken I
    J Mol Recognit; 1996; 9(5-6):347-55. PubMed ID: 9174908
    [No Abstract]   [Full Text] [Related]  

  • 6. [Growth and differentiation of eosinophils--special reference to IL-5 and its receptor].
    Akutsu I; Takatsu K
    Nihon Rinsho; 1993 Mar; 51(3):557-64. PubMed ID: 8492427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine recognition by human interleukin 5 receptor.
    Ishino T; Robertson N; Chaiken I
    Vitam Horm; 2005; 71():321-44. PubMed ID: 16112273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional bipartite nuclear localisation signal in the cytokine interleukin-5.
    Jans DA; Briggs LJ; Gustin SE; Jans P; Ford S; Young IG
    FEBS Lett; 1997 Apr; 406(3):315-20. PubMed ID: 9136909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-5 and IL-5 receptor expression on human eosinophils in relation to eosinophil activation.
    Chihara J; Capron M; Nakajima S
    Biotechnol Ther; 1993; 4(3-4):271-83. PubMed ID: 8292975
    [No Abstract]   [Full Text] [Related]  

  • 10. Creation of a biologically active interleukin-5 monomer.
    Dickason RR; Huston DP
    Nature; 1996 Feb; 379(6566):652-5. PubMed ID: 8628400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interleukin-5 as a differentiation factor for eosinophilic granulocytes. Its biological effects and potential therapeutic uses].
    Kubin R
    Dtsch Med Wochenschr; 1992 Feb; 117(8):307-12. PubMed ID: 1537269
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interleukin-5].
    Yamaguchi Y
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1287-93. PubMed ID: 8031174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding interactions of human interleukin 5 with its receptor alpha subunit. Large scale production, structural, and functional studies of Drosophila-expressed recombinant proteins.
    Johanson K; Appelbaum E; Doyle M; Hensley P; Zhao B; Abdel-Meguid SS; Young P; Cook R; Carr S; Matico R
    J Biol Chem; 1995 Apr; 270(16):9459-71. PubMed ID: 7721873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single chain human interleukin 5 and its asymmetric mutagenesis for mapping receptor binding sites.
    Li J; Cook R; Dede K; Chaiken I
    J Biol Chem; 1996 Jan; 271(4):1817-20. PubMed ID: 8567620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-5 and its receptor: which role do they play in the immune response?
    Koike M; Takatsu K
    Int Arch Allergy Immunol; 1994 May; 104(1):1-9. PubMed ID: 7950399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-5 and its receptor system: implications in the immune system and inflammation.
    Takatsu K; Takaki S; Hitoshi Y
    Adv Immunol; 1994; 57():145-90. PubMed ID: 7872157
    [No Abstract]   [Full Text] [Related]  

  • 17. Soluble interleukin-5 receptor alpha-chain binding assays: use for screening and analysis of interleukin-5 mutants.
    Banks M; Graber P; Proudfoot AE; Arod CY; Allet B; Bernard AR; Sebille E; McKinnon M; Wells TN; Solari R
    Anal Biochem; 1995 Sep; 230(2):321-8. PubMed ID: 7503425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of regions within the third FnIII-like domain of the IL-5Ralpha involved in IL-5 interaction.
    Czabotar PE; Holland J; Sanderson CJ
    Cytokine; 2000 Jul; 12(7):867-73. PubMed ID: 10880230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the interaction between human interleukin-5 and the soluble domain of its receptor using a surface plasmon resonance biosensor.
    Morton TA; Bennett DB; Appelbaum ER; Cusimano DM; Johanson KO; Matico RE; Young PR; Doyle M; Chaiken IM
    J Mol Recognit; 1994 Mar; 7(1):47-55. PubMed ID: 7986567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-5, a therapeutic target in allergic inflammation.
    Huston DP; Huston MM; Dickason RR; Martinez-Moczygemba M
    Trans Am Clin Climatol Assoc; 2000; 111():46-59; discussion 59-60. PubMed ID: 10881331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.